Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas D. Nguyen
Observed names:
Nguyen, Thomas D.,
Thomas D Nguyen
Institution:
University at Buffalo, State University of New York
Observed institutions:
Scripps Research Institute,
Zoological Society of San Diego,
San Diego Zoo Institute for Conservation Research,
University at Buffalo, State University of New York
ORCID:
0009-0000-1069-1720
Observed ORCID:
0009-0000-1069-1720
OpenAlex ID:
A5061995965
Rewinding Extinction in the Northern White Rhinoceros: Genetically Diverse Induced Pluripotent Stem Cell Bank for Genetic Rescue
2021
·
Marisa L. Korody
, Sarah M. Ford
, et al.
·
Stem Cells and Development
·
44
A mechanism-based pathway toward administering highly active N-phage cocktails
2023
·
Nicholas M. Smith
, Thomas D. Nguyen
, et al.
·
Frontiers in Microbiology
·
23
PDF
Four new induced pluripotent stem cell lines produced from northern white rhinoceros with non-integrating reprogramming factors
2017
·
Marisa L. Korody
, Cullen Pivaroff
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
17
PDF
Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model
2025
·
Arne Echterhof
, Tejas Dharmaraj
, et al.
·
Antimicrobial Agents and Chemotherapy
·
15
Machine Learning‐Led Optimization of Combination Therapy: Confronting the Public Health Threat of Extensively Drug Resistant Gram‐Negative Bacteria
2023
·
Nicholas M. Smith
, Thomas D. Nguyen
, et al.
·
Clinical Pharmacology & Therapeutics
·
8
Bayesian optimization of tacrolimus exposure in stable kidney transplant patients
2023
·
Thomas D. Nguyen
, Nicholas M. Smith
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
8
PDF
Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy
2021
·
Nicholas M. Smith
, Arthur Chan
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
5
PDF
Pharmacodynamic individualization of phage therapy against a KPC-5-producing Pseudomonas aeruginosa
2025
·
Thomas D Nguyen
, Jacob T Sanborn
, et al.
·
JAC-Antimicrobial Resistance
·
3
Bacterial Mixology: Combining Pharmacodynamic Models to Predict In Vitro Competition of MCR-1-Harboring E. coli
2021
·
Nicholas M. Smith
, Arthur Chan
, et al.
·
Antibiotics
·
1
PDF
Rewinding Extinction in the Northern White Rhinoceros: Genetically Diverse Induced Pluripotent Stem Cell Bank for Genetic Rescue
2026
·
SDZWA Admin
, Marisa L. Korody
, et al.
·
San Diego Zoo Wildlife Alliance
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa
2026
·
Claire Han
, Karishma Patel
, et al.
·
Antimicrobial Agents and Chemotherapy
Translational Quantitative Proteomic Assay for Bacteriophages: Opening a Frontier in Phage Pharmaceutical Development
2026
·
Thomas D. Nguyen
, Connor E. Gould
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
MassIVE MSV000101576 - Targeted Proteomics for Quantitation of Pseudomonas aeruginosa Podovirus LUZ19
2026
·
Nguyen, Thomas D.
·
UC San Diego
Mapping the Proteomes of Bacteriophages E215 and LUZ19 Using Liquid Chromatography Tandem Mass Spectrometry
2026
·
Connor E. Gould
, Alhaji Simon Ekere
, et al.
·
Advances in experimental medicine and biology
Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter Baumannii
2025
·
Brian M. Ho
, Jingxiu Jin
, et al.
·
Pharmaceuticals
PDF
Show more works
View as search
Works count:
15
Citation count:
124
H-index:
6
I10-index:
4
Year
Topic
Type